Abstract
Although microbiome–host interactions are usual at steady state, gut microbiota dysbiosis can unbalance the physiological and behavioral parameters of the host, mostly via yet not understood mechanisms. Using the Drosophila model, we investigated the consequences of a gut chronic dysbiosis on the host physiology. Our results show that adult flies chronically infected with the non-pathogenic Erwinia carotorova caotovora bacteria displayed organ degeneration resembling wasting-like phenotypes reminiscent of Metabolic Syndrome associated pathologies. Genetic manipulations demonstrate that a local reduction of insulin signaling consecutive to a peptidoglycan-dependent NF-κB activation in the excretory system of the flies is responsible for several of the observed phenotypes. This work establishes a functional crosstalk between bacteria-derived peptidoglycan and the immune NF-κB cascade that contributes to the onset of metabolic disorders by reducing insulin signal transduction. Giving the high degree of evolutionary conservation of the mechanisms and pathways involved, this study is likely to provide a helpful model to elucidate the contribution of altered intestinal microbiota in triggering human chronic kidney diseases.
Similar content being viewed by others
Introduction
The human intestinal microbiota maintains a symbiotic relationship with its host under normal conditions. However, persistent modifications in the composition and/or in the function of this gut microbial population are associated with several pathologies, including metabolic diseases1,2. Among them, Metabolic Syndrome (MetS), a systemic disease also termed as dysmetabolic syndrome, is a world health concern thought to be caused by an underlying disorder of energy utilization and storage that directly increase the risk of diabetes mellitus type 2 as well as cardiovascular and renal diseases3,4. Although modifications in microbiota have been associated with MetS, it remains unclear whether the presence of keystone bacterial species in the gut is required for triggering the metabolic imbalance associated with the pathologies5,6. Increasing evidence however suggest that gut bacteria contribute to metabolic disturbances via the stimulation of low-grade inflammation of the gut and distal organs such as lung, brain, liver and kidney2,7,8. It is postulated that the translocation of gut bacterial pro-inflammatory metabolites and/or compounds to the circulation could trigger or at least facilitate systemic inflammation and mediate metabolic disorders leading to disease9. In most cases, the nature of the metabolites involved and their mode of action remain unknown.
Peptidoglycan (PGN) is a ubiquitous bacteria cell wall component for which the innate immune systems of plants, vertebrates and invertebrates have evolved various classes of sensing pattern recognition receptors among which NODs (Nucleotide Oligomerization Domains) and PGRPs (PeptidoGlycan‐Recognition Proteins) are the most studied10,11,12,13. Released by most dividing Gram-positive and Gram-negative gut bacteria, regardless of whether they are symbionts, pathogens, or pathobionts, PGN can be detected throughout the body suggesting a systemic diffusion from the gut microbiota14,15,16,17. In Drosophila, the direct binding of PGN to specific membrane-associated (PGRP-LC) or cytosolic (PGRP-LE) receptors triggers the production of hundreds of NF-κB-dependent immune effectors and regulators that could contribute consequently to inflammatory responses upon gut homeostatic imbalance such as alteration of microbiota18,19,20. A growing body of research in both invertebrate and vertebrate models continues to mount that microbiota-derived PGN could have systemic effects on metabolism and behaviors21,22,23. However, the causal relationships that underlie the systemic dissemination of PGN in promoting metabolic disorders and subsequent diseases are complex and not yet fully understood.
Studies on model organisms have provided valuable insights into genetic diseases in general and in the molecular mechanisms by which the gut microbiota is associated with innate immunity and metabolic disorders in particular24,25,26,27. Therefore, we used a Drosophila model of bacterial enteric dysbiosis to study the consequences of gut-derived PGN on the host’s physiology. A persistent dysbacteriosis can be established in flies by oral infection with the non-pathogenic Gram-negative enterobacteria Erwinia caratovora caratovora (Ecc)14,28,29. Sensing of Ecc-derived PGN triggers local and systemic activation of the IMmune Deficiency (IMD) signaling cascade, a NF-κB-dependent pathway that shares similarities with the mammalian Tumor-Necrosis-Factor Receptor1 (TNF-R1) pathway30. Combining phenotypic and comprehensive genetic analysis, we found that chronic systemic inflammation induced by gut-derived PGN causes a wasting syndrome whereby the abdomen becomes swollen due to fluid accumulation and the fat body and ovaries are almost degenerated31,32. We demonstrate that fluid buildup and fat body wasting are the direct consequence of a NF-κB-dependent local reduction of the insulin/PI3K signaling within the Malpighian tubules, the insect’s equivalent of kidneys. Altogether, this study provides support for the role of PGN as a specific bacteria-derived metabolite contributing to the onset of organ wasting and identifies the Malpighian tubules as major organs integrating immune and metabolic signals.
Results
Chronic enteric dysbiosis provokes a NF-κB-dependent fat body degeneration and bloating
To evaluate the impact of chronic enteric dysbiosis on fly homeostasis, wild-type flies were contaminated every two days with a fresh solution of Ecc14. This entomopathogenic Gram-negative bacteria has been shown to release its cell-wall PGN which represents a strong elicitor of the innate immune signaling cascades in both flies and mammals11,33. In orally infected flies, gut-born bacteria PGN acts both at a short-range by triggering the IMD/NF-κB pathway in the surrounding enterocytes but also systemically in the whole animal after having crossed the gut epithelium and diffused into the hemolymph14,15. Consistently, while a short exposure to Ecc led to a rapid and transient activation of the IMD pathway (monitored through the transcription of one of its targets, the antimicrobial peptide gene Diptericin) without consequences on lifespan, persistent recolonization of the gastrointestinal tract with Ecc provoked a constant systemic activation of the NF-κB pathway and a premature death of the flies (Fig. 1A,B). From previous work, we expected that Ecc-dependent reduced life span was a direct consequence of PGN-mediated NF-κB pathway activation34,35. Indeed, lethality was worsened in absence of PGRP-LB, an amidase that reduces the intensity of the immune response by specifically degrading PGN, and partially rescued by genetically blocking the NF-κB cascade via the Dredd mutation (Fig. 1C and Sup Fig. 1). In order to evaluate the physiological consequences associated with PGN-dependent chronic NF-κB activation, we assessed putative internal organ damages. We observed that the fat body, an organ that preserves energy in the form of lipid droplets displayed very strong infection-dependent phenotypes. While fat body cells of non-infected flies covered the entire internal cuticle surface, the same tissue in chronically infected flies presented evident signs of degeneration with parts of the abdomen cuticle no longer covered by fat body cells (Fig. 1D and Sup Fig. 2A). Consistent with an infection-dependent wasting of the adipose tissue, a strong reduction of lipid droplets, the main organelle of fat storage, was observed in Ecc chronically fed flies, as compared to controls (Sup Fig. 2B). Moreover, almost 25% of chronically infected animals displayed a completely degenerated fat body and developed a severe “bloating phenotype” characterized by translucent and distended abdomens associated with a permanently extended proboscis (Fig. 1D,E, Sup Fig. 3A). We hypothesized that this abdominal bloating could arise from the accumulation of internal gas or fluid retention. Piercing inflated flies led to abdominal deflation without gas bubbles (data not shown). In addition, weight measurements revealed that chronically infected flies were almost twice as heavy as controls (Fig. 1F). Taken together, these results indicate that abdominal swelling is due to fluid accumulation. Furthermore, oral infection provoked an almost complete degeneration of ovaries associated with a massive increase in the percentage of apoptotic ovarioles (Fig. 1G–I and Sup Fig. 3B). The penetrance and the severity of all these phenotypes were decreased in the Dredd mutant background demonstrating that they were indeed the consequences of IMD pathway activation (Fig. 1D–I and Sup 2B). Altogether, our results demonstrate that a continuous activation of NF-κB signaling by bacteria-derived PGN induces fluid accumulation as well as fat body and ovary wasting, a systemic phenotype relevant to the wasting syndrome caused by metabolic disorders and reminiscent of MetS in mammals31,32.
Chronic NF-κB signaling in enterocytes or adipocytes does not cause a wasting syndrome
Bacterial metabolites, other than PGN, can influence the host homeostasis9. For example, by producing Uracil, Ecc is inducing NADPH oxidase-dependent ROS production in the gut36. To probe the specific role of the PGN-dependent IMD activation in the apparition of a wasting syndrome, we tested whether activation of NF-κB signaling in the absence of bacteria could provoke phenotypes observed upon Ecc infection. By combining the binary system Gal4/UAS and the temperature-sensitive repressor Gal80ts, we observed that activation of the NF-κB cascade in adult tissues, via ubiquitous overexpression of IMD using the DaGal4 driver, was sufficient to recapitulate all Ecc-triggered phenotypes confirming that they are the result of chronic activation of the immune system (Fig. 2, Sup Fig. 2C and Sup Fig. 4). Upon enteric dysbiosis, Ecc-derived PGN first triggers local activation of NF-κB signaling in enterocytes before activating a systemic immune response in fat body cells14,15. Constant activation of NF-κB signaling in enterocytes by overexpressing IMD using the MexGal4 driver (Sup Fig. 4) impacted fly lifespan but did not provoke fluid accumulation and had no obvious effect on fat body or ovary integrity (Fig. 2). Since the fat body is a multifunctional tissue implicated in energy storage, immune response and a major endocrine organ that secretes proteins governing oocyte maturation, we then tested whether constant NF-κB signaling in this tissue could recapitulate the phenotypes associated with Ecc chronic infection. To our surprise, although IMD/NF-κB pathway activation by overexpressing IMD in fat body cells using the R4Gal4 driver (Sup Fig. 4) significantly reduced fly lifespan, it did not caused abdominal bloating and had no obvious impact on the integrity of the fat body itself or on the ovaries (Fig. 2). Identical results were obtained when the IMD cascade was activated in the enterocytes or in the fat body cells of adult flies via the overexpression of the PGRP-LCa receptor (Sup Fig. 5)37. While chronic activation the IMD cascade in enterocytes or fat body cells reduces lifespan and might be involved in the premature death caused by Ecc chronic infection, the absence of degenerative phenotypes could reflect the need for synergistic activity of IMD activation in different tissues. Alternatively, it could also suggest that Ecc-dependent homeostasis disruption is the consequence of IMD pathway activation in PGN responding tissues other than the gut and the fat body and yet to be identified.
NF-κB activation in Malpighian tubules mediates Ecc-induced fluid accumulation and fat body wasting
Abdominal swelling due to accumulation of fluid has been previously shown to be symptomatic of a failure of Malpighian tubules (MTs), an organ highly specialized in organic solute transport, metabolism and detoxification38,39. As MTs also constitute an autonomous immune-sensing tissue20,40, we tested the consequences of chronic NF-κB activation in the Malpighian tubule cells in the absence of infection. Drosophila Malpighian tubules are made of four tubules that consist of two cell types and ∼150 cells. Type I cells, also known as principal cells, through which cations and organic solutes are transported, are the major tubule cell type (~ 80%). Type II cells, also called stellate cells, through which water and chloride ion flow, are interspersed at regular intervals with the type I cells41. Interestingly, activating the NF-κB pathway in adult flies by overexpressing IMD or PGRP-LCa in either cell type using LKRGal4 driver for stellate cells and C42Gal4 driver for principal cells (Sup Fig. 4) provoked premature death of the flies and recapitulated Ecc-triggered fluid retention and fat body wasting but not ovary degeneration (Fig. 2 and Sup Fig. 5). These results were confirmed using two independent drivers, UroGal4 for the principal cells and Tret-1Gal4 for the stellate cells (Sup Figs. 4 and 6). Simultaneous activation of the NF-κB pathway in principal and stellate cells strongly reduced fly longevity and accelerated the onset of the abdominal swelling and fat body depletion phenotypes without affecting ovary integrity (Sup Fig. 7). Collectively, these results suggest that activation of the NF-κB pathway in either cell type of Malpighian tubules can act in parallel to cause death by inducing progressive deterioration of MTs function and distant fat body wasting but preclude a direct involvement in the ovary degeneration caused by enteric dysbiosis.
Intracellular detection of PGN by MT cells activates NF-κB signaling and causes fluid retention and fat body wasting
To confirm that NF-κB pathway activation in the MTs is the trigger of Ecc-mediated fluid accumulation and fat body degeneration, we analyzed the immune status of the MTs of Ecc-orally infected flies. Antimicrobial peptide (AMP) targets of the IMD/NF-κB pathway but not of the Toll/NF-κB pathway, were highly induced in MTs 24 h after Ecc oral infection (Fig. 3A). This activation was almost fully suppressed when the IMD pathway adaptor Fadd was specifically inactivated via RNAi in principal cells suggesting that these cells ensure the main production of antimicrobial peptides in response to PGN during enteric dysbiosis (Fig. 3B). In addition, elimination of the cytosolic PGN receptor PGRP-LE, but not the transmembrane receptor PGRP-LC, was also sufficient to abolish the Ecc-dependent activation of AMP genes in MTs suggesting an intracellular detection of PGN (Fig. 3C,D)18,20. These results were confirmed using the cytosolic PGN-degrading enzyme, PGRP-LBRD15. Specific expression of PGRP-LBRD in principal cells completely prevented IMD/NF-κB AMP targets induction in adult flies 24 h after Ecc feeding (Fig. 3E). Consistently, reducing IMD pathway activation either via RNAi-mediated inactivation of PGRP-LE, or via PGRP-LBRD overexpression, was sufficient to partially rescue the Ecc-triggered lethality and to reduce the penetrance of the bloating phenotype and fat body wasting without bettering the ovary atrophy (Fig. 3F,J and Sup Fig. 8). Altogether, these data demonstrate that, by activating NF-κB within Malpighian tubule cells, gut-born Ecc PGN contributes to infection-induced fluid accumulation and fat body wasting.
Chronic activation of NF-κB interrupts insulin/PI3K signaling in MTs
Reduction of the metabolic insulin/PI3K signaling cascade is a central feature to development of metabolic disturbances in mammals in general and in Drosophila in particular20,31,42. We therefore asked whether the effects of PGN on MTs could be mediated by a local inhibition of this pathway. We first tested the consequences of gut chronic infection on the well-characterized insulin/PI3K target gene 4EBP which transcription is increased when insulin signaling is antagonized31,43. Chronical Ecc feeding was sufficient to increase 4EBP transcription in MTs, a feature of a local PI3K/insulin signaling downregulation (Fig. 4A). This activation was fully abrogated when either PGRP-LE or Fadd were silenced via RNAi (Fig. 4B and Sup Fig. 9A) or after the overexpression of PGRP-LBRD in the principal cells of Ecc-infected flies (Sup Fig. 9B). To assess whether IMD-dependent insulin signaling decrease in MTs was involved in the different phenotypes associated with the wasting syndrome, we probe whether expressing a constitutive active form of PI3K (PI3KCAAX) in MT principal cells could rescue the Ecc-mediated phenotypes. We observed that the Ecc-induced lethality, the bloating phenotype and the fat body wasting but not the degeneration of ovaries were partially rescued by restoring the PI3K cascade in MT principal cells (Fig. 4C–G). Altogether, these results show that chronic activation of the IMD pathway by bacteria-derived PGN leads to a local reduction of the insulin/PI3K pathway in MTs causing fluid accumulation and fat body wasting.
Impaired FoxO and TOR metabolic signaling in MTs provoke fluid buildup and fat body wasting
The evolutionary conserved transcription factor FoxO (Forkhead box O) and TOR (Target of Rapamycin) complex mediate most of the PI3K/insulin signaling metabolic effects44,45. These key effectors are involved in the integration of environmental cues and their translation into metabolic responses46. Alterations in insulin signaling result in both FoxO nuclear translocation and consequent transcription of target genes and inhibition of the TOR complex. We, therefore, tested whether either FoxO activation or TOR inhibition in MTs was sufficient to recapitulate the consequences of PI3K/insulin signaling reduction in the excretory system during enteric dysbiosis. Indeed, specific expression of a constitutive active form of FoxO (FoxO™)43 either in the Malpighian principal or stellate cells in non-infected flies reduced life span and provoked a bloating phenotype associated with fat body depletion but did not affect the integrity of ovaries (Fig. 5A–F). Similarly, overexpression of the heterodimeric tuberous sclerosis complex TSC1/TSC2, the main inhibitor of TOR47, was sufficient to provoke abdominal swelling and fat body degeneration but had not impact on the integrity of ovaries (Fig. 5G–L). Altogether these results plead in favor of a model in which local reduction of PI3K/insulin signaling in MTs caused by the activation of NF-κB by gut-derived PGN alters FoxO and TOR metabolic signaling, and in fine provoke imbalance in fluid homeostasis and wasting of the fat body.
Discussion
MetS, defined by a clustering of metabolic disorders affecting multiple interacting organ systems, is a worldwide health concern with high morbidity and mortality3. Recent studies in animal models and in humans support a link between persistent low-grade inflammation caused by microbiota-derived metabolites and various components of MetS-associated chronic diseases5,48. The identification of these metabolites and their mechanisms of action are therefore critical for uncovering the role exerted by bacterial ecosystems on the setting of metabolic diseases. This study establishes a clear crosstalk between bacteria-derived PGN and an immune NF-κB signaling that contributes to the onset of metabolic disorders in Drosophila. Adult flies chronically infected with the enterobacteria Ecc develop phenotypes that are associated with impaired metabolic homeostasis including fluid buildup as well as fat body and ovary degeneration31,32. We made the demonstration that systemic activation of the IMD/NF-κB cascade by gut-derived PGN is the main elicitor of these physio-pathologic consequences. Our data clearly indicate that upon chronic enteric dysbiosis, a specific NF-κB-dependent reduction of insulin/PI3K signaling in MTs is the trigger of fluid accumulation and fat body wasting but not ovary atrophy. It is noteworthy that interruption of systemic insulin signaling by ImpL2, which antagonizes insulin signaling by binding to Drosophila insulin-like peptides (DILPs), and bacteria-derived PGN cause a wasting syndrome affecting fluid homeostasis, fat body and ovaries31,49. Thus, it will be of future interest to determine whether chronic IMD pathway activation in PGN responding organs other than MTs also impact local or systemic insulin/PI3K signaling.
Previous reports have linked bacteria-immunity and insulin signaling in flies, although most studies have been performed at the larval stage. Persistent activation of IMD was shown to deplete fat reserves, cause hyperglycemia, delay development, and impair larval growth suggesting that IMD influences metabolic regulatory pathways50. Humoral infection with the bacterial pathogen Mycobacterium marinum, a close relative of M. tuberculosis causes a progressive loss of metabolic energy stores in form of fat and glycogen leading to a wasting-like phenotype. This wasting response is in part the consequence of inhibition of the insulin signaling and consequent activation of the transcription factor FoxO51. Finally, activation in the larval fat body of the Toll pathway, the other fly NF-κB signaling cascade, was shown to block insulin-dependent growth and nutrient storage. Since DILP6 is a selective target of Toll signaling, it was proposed that Toll signaling reduces growth by inducing hormone insufficiency in the case of infection52. Whereas most studies have identified the fat body as the main tissue integrating immune and metabolic signals, we showed that the wasting syndrome caused by bacteria-derived PGN is largely fat body independent. Indeed, it is in part the consequence of a PGN dependent insulin signaling reduction in the excretory system highlighting that Malpighian tubules are essential organs for the maintenance of immune and metabolic homeostasis in adult flies. It is interesting to note that PGN from Gram-positive bacteria, called Lys-type PGN is filtered by another component of the excretory system of the insects, the nephrocytes. In flies with no functional nephrocytes, Lys-type PGN accumulate in the hemolymph leading to Toll/NF-kB constitutive activation which is detrimental for the flies53.
How is IMD activation impairing the insulin pathway in the renal tubules and how the local reduction of this metabolic pathway impacts remote organs such as the fat body remain open questions. One model will involve a modulation of the levels of circulating DILPs. Indeed, although in adult flies the metabolic role of DILPs appears complex, a reduction of expression of these insulin analogs has been suggested to cause infection-induced wasting51. In MTs, DILP5 produced by principal cell acts as a local insulin agonist whose expression is modulated upon multiple stress conditions54. Therefore, during enteric dysbiosis, a NF-κB dependent reduction of DILP5 production or release by MTs could locally impair insulin signaling hence affecting renal functions. It could also perturb peripheral target organs for insulin including the fat body. Interestingly, DILP5 production by MTs is under the control of tachykinin, an endocrine peptide produced by the enteroendocrine gut cells in an IMD-dependent manner54.
Altogether, our results provide compelling evidence that bacteria-derived PGN triggers IMD/NF-κB pathway activation and metabolism disorders in MTs contributing to organ failure and distant fat storage wasting in flies. It is worth to note the remarkable parallels between the results obtained and the physiopathology of the human Chronic Kidney Disease (CKD), a MetS-associated chronic pathology. Mounting evidence show that alterations of gut microbiota play a key role in CKD and cause systemic NF-κB mediated inflammation and alteration of the insulin/PI3K metabolic signaling55,56. CDK is characterized by a slow and progressive loss of glomerular filtration rate leading to kidney failure and fluid retention57. The complications of this disease also impact beyond the kidney and CKD is associated with multiple physiological and metabolic disturbances including muscle and fat storage wasting58. Based on the relevance of Drosophila MTs as a model for human renal diseases and the conservation of immune–metabolic interactions from invertebrates to vertebrates59, it is tempting to propose that low grade inflammation caused by PGN contributes to the onset of metabolic diseases such as CKD. If so, circulating PGN could be used as an early diagnostic biomarker or a novel therapeutic target to prevent chronic inflammation associated with gut dysbiosis in MetS. The recent validation of the first blocking anti-PGN antibody is, in this respect, an important first step57.
Methods
Drosophila melanogaster strains and maintenance
The w1118 (BL #6326) flies was used as the reference control wild-type strain. The PGRP-LBΔ34 and DreddD5560 mutant strains were generous gifts of B. Lemaitre. The following strains were obtained from the Bloomington Stock Center: DaGal4 (BL#55851), R4Gal4 (BL#33832), C42Gal4 (BL#30835), UroGal4 (BL#44416), TubGal80ts (BL#7018 and BL#7019), UAS-PI3KCAAX (BL#8294), UAS-RelishRNAi (BL#28943), UAS-PGRP-LERNAi (BL#60038) and UAS-mCD8RFP (BL#27398). The UAS-FaddRNAi and UAS-PGRP-LCRNAi lines were kindly provided by Meier61, and Lemaitre19. The drivers LKRGal4 and Tret1-1Gal4 were kindly provided by Al-Anzi62 and Schirmeier63, respectively. The UAS-PGRP-LBRD strain was described elsewhere63. The UAS-FoxO™ was kindly provided to our laboratory by Tatar43. The fly stocks used for this study also include MexGal464, UAS-PGRP-LCa37 and UAS-TSC1/2 strains65. Unless otherwise indicated, flies were grown at 25 °C on a yeast/cornmeal medium in 12 h/12 h light/dark cycle-controlled incubators. Flies of genotypes containing the Gal4/UAS/Gal80ts constructs were reared at 20 °C and transferred to 29 °C as 5-day-old adults to allow the expression of the Gal4 transcription factor. The five days of adulthood prior to the onset of Gal4 expression are required to allow maturation of adult structures. Female flies were used for all experiments.
Drosophila culture media
For 1liter of food, 8.2 g of agar (VWR, cat. #20768.361), 80 g of cornmeal flour (Westhove Maize H1) and 80 g of yeast extract (VWR, cat. #24979.413) were cooked for 10 min in boiling water. 5.2 g of Methylparaben sodium salt (Merck, cat. #106756) and 4 ml of 99% propionic acid (CARLO ERBA, cat. #409553) were added when the food had cooled down. For antibiotic (ATB) treatment, standard medium was supplemented with Ampicillin, Kanamycin, Tetracyclin and Erythromycin at 50 μg/ml final concentrations15.
Infection of adult flies by Ecc and survival assays15
The bacterial strain used in this study is Erwinia carotovora carotovora 15 (Ecc) cultured in Luria–Bertani (LB) medium at 30 °C overnight. Bacterial cultures were centrifuged at 2,500g for 20 min at RT. Cells were serially diluted in PBS and their concentration was determined by optical density (OD) measurement at 600 nm. For oral infection and subsequent analysis, 5-day-old females raised from egg-to-adult in presence of ATB in the food were used. 24 h before the infection, flies were transferred in vials without ATB and then placed in a fly vial with Ecc contaminated food. This food solution was obtained by mixing a pellet of an overnight culture of bacteria Ecc (OD = 200) with a solution of 5% sucrose (50/50) and added to a filter disk that completely covered the agar surface of the fly vial. To perform survival assays upon chronic infection, flies were infected every 2 days with a fresh solution of Ecc (OD = 200) with a solution of 5% sucrose (50/50). For kinetics involving an acute exposure to Ecc, flies were in contact with infected food for 5 h before being transferred to vials containing a filter disk soaked in a food solution of LB medium with of 5% sucrose (50/50) in presence of ATB. Survival analysis in absence of infection were conducted in vials containing a food solution of LB medium and a solution of 5% sucrose (50/50) in presence of ATB. Dead flies were scored at a set time once a day. A minimum of three vials of 25 flies were used for each survival assay. Experiments were repeated at least twice15. Statistical analyses used one-sided log rank test within Prism (GraphPad software).
Organ wasting analysis and ovarian health quantification
The penetrance of the abdominal bloating was analyzed during dedicated kinetics at a set time once a day until all flies were dead. In practice, flies were anesthetized with CO2 and observed individually under a stereo microscope. Those displaying a translucent and distended abdomen were scored and transferred to a different fly vial. At least three vials of 25 flies were used for each assay. Statistical analyses used the Fisher’s exact test within Prism (GraphPad software). For neutral lipid staining, carcass/fat body of control and infected flies were dissected in cold PBS, fixed for 30 min in 4% paraformaldehyde on ice, rinse 3 times in PBS and stained with BODIPY 493/503 at 1:1,000 in PBS for 30 min. Ovarian degeneration was determined after dissection by direct observation and quantification of the substantial reduction in ovarian size and loss of mature eggs at 50% of lethality. A minimum of 20 ovaries were analyzed in each assay. Experiments were conducted in triplicate. Statistical analyses used Mann–Whitney test within Prism (GraphPad software). Ovarian health was quantified as the percentage of ovarioles that contained one or more apoptotic egg chamber at stage 9–1049. Briefly, ovaries were dissected in PBS and fixed 30 min in 4% paraformaldehyde on ice. DAPI staining was used as a tool to visualize egg chambers throughout oogenesis and identify those that are dying during mid-oogenesis66. For each experimental condition, a minimum of one hundred ovarioles from at least 20 ovaries were analyzed on fluorescence microscope with UV. Statistical analyses used the Mann–Whitney test within Prism (GraphPad software).
Fly weight measurements
To measure body weight, female flies (n = 24) were anaesthetized with CO2, transferred to Eppendorf tubes and weighed on a METTLER TOLEDO precision balance.
Quantitative real-time PCR
RNA from whole adult animals or dissected organs (n = 15) was extracted with RNeasy Mini Kit (QIAGEN, cat. #74106). Quantitative real-time PCR, TaqMan, and SYBR Green analysis were performed as previously described15. The amount of mRNA detected was normalized to control rp49 mRNA values. Normalized data was used to quantify the relative levels of a given mRNA according to cycling threshold analysis (ΔCt). Control and experimental conditions were tested in the same ‘run’. Each sample was normalized to its own rp49 control to take into account age-specific changes in gene expression. Results are presented as average and standard deviation of a minimum of three independent experiments. Statistical analyses used Mann–Whitney test, within Prism (GraphPad software).
qRT-PCR primers
Primers used for qRT-PCR are for:
-
rp49: GACGCTTCAAGGGACAGTATCTG, AAACGCGGTTCTGCATGA
-
Diptericin: GCTGCGCAATCGCTTCTACT, TGGTGGAGTGGGCTTCATG
-
Metchnikovin: GATGCAACTTAATCTTGGAGCG, TTAATAAATTTGGACCCGGTCTTGGTTGG
-
Cecropin: ATGAACTTCTACAACATCTTCG, GGCAGTTGCGGCGACATTGGCG
-
Attacin A: CCCGGAGTGAAGGATG, GTTGCTGTGCGTCAAG
-
Attacin D: GTCACTAGGGTTCCTCAG, GCCGAAATCGGACTTG
-
Drosomycin: CGTGAGAACCTTTTCCAATATGATG, TTCCACGACCACCAGCAT
-
Defensin: GTTCTTCGTTCTCGTGG, CTTTGAACCCCTTGGC
-
4EBP: CATGCAGCAACTGCCAAATC, CCGAGAGAACAAACAAGGTGG
Gal4 expression profile imaging
Dissected organs (intestine, Malpighian tubules and carcass/fat body) from 4–6-day old female flies expressing the membrane tagged red fluorescent protein mCD8RFP under the control of the Gal4 drivers used in this work were fixed for 20 min in 4% paraformaldehyde on ice and rinse 3 times in PBT (PBS + 0.3% Triton X-100). DAPI staining was used as a tool to visualize nuclei. Tissues were then mounted in VECTASHIELD (Vector Laboratories) fluorescent mounting medium. Images were captured with a LSM 780 ZEISS confocal microscope and processed using Adobe Photoshop.
References
Cani, P. D. Microbiota and metabolites in metabolic diseases. Nat. Rev. Endocrinol. 15, 69–70 (2019).
Tilg, H., Zmora, N., Adolph, T. E. & Elinav, E. The intestinal microbiota fuelling metabolic inflammation. Nat. Rev. Immunol. 20, 40–54 (2020).
Saklayen, M. G. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep 20, 12 (2018).
Singh, A. K. & Kari, J. A. Metabolic syndrome and chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 22, 198–203 (2013).
Dabke, K., Hendrick, G. & Devkota, S. The gut microbiome and metabolic syndrome. J. Clin. Investig. 129, 4050–4057 (2019).
Mazidi, M., Rezaie, P., Kengne, A. P., Mobarhan, M. G. & Ferns, G. A. Gut microbiome and metabolic syndrome. Diabetes Metab. Syndr. 10, S150-157 (2016).
Meijers, B., Evenepoel, P. & Anders, H. J. Intestinal microbiome and fitness in kidney disease. Nat. Rev. Nephrol. 15, 531–545 (2019).
Yang, T., Richards, E. M., Pepine, C. J. & Raizada, M. K. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nat. Rev. Nephrol. 14, 442–456 (2018).
Lee, W. J. & Hase, K. Gut microbiota-generated metabolites in animal health and disease. Nat. Chem. Biol. 10, 416–424 (2014).
Gust, A. A. Peptidoglycan perception in plants. PLoS Pathog 11, e1005275 (2015).
Irazoki, O., Hernandez, S. B. & Cava, F. Peptidoglycan muropeptides: Release, perception, and functions as signaling molecules. Front. Microbiol. 10, 500 (2019).
Motta, V., Soares, F., Sun, T. & Philpott, D. J. NOD-like receptors: Versatile cytosolic sentinels. Physiol. Rev. 95, 149–178 (2015).
Royet, J., Gupta, D. & Dziarski, R. Peptidoglycan recognition proteins: Modulators of the microbiome and inflammation. Nat. Rev. Immunol. 11, 837–851 (2011).
Basset, A. et al. The phytopathogenic bacteria Erwinia carotovora infects Drosophila and activates an immune response. Proc. Natl. Acad. Sci. USA 97, 3376–3381 (2000).
Charroux, B. et al. Cytosolic and secreted peptidoglycan-degrading enzymes in Drosophila respectively control local and systemic immune responses to microbiota. Cell Host Microbe 23, 215–228.e214 (2018).
Gendrin, M., Welchman, D. P., Poidevin, M., Herve, M. & Lemaitre, B. Long-range activation of systemic immunity through peptidoglycan diffusion in Drosophila. PLoS Pathog 5, e1000694 (2009).
Hergott, C. B. et al. Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis. Blood 127, 2460–2471 (2016).
Bosco-Drayon, V. et al. Peptidoglycan sensing by the receptor PGRP-LE in the Drosophila gut induces immune responses to infectious bacteria and tolerance to microbiota. Cell Host Microbe 12, 153–165 (2012).
Iatsenko, I., Kondo, S., Mengin-Lecreulx, D. & Lemaitre, B. PGRP-SD, an extracellular pattern-recognition receptor, enhances peptidoglycan-mediated activation of the Drosophila Imd pathway. Immunity 45, 1013–1023 (2016).
Kaneko, T. et al. PGRP-LC and PGRP-LE have essential yet distinct functions in the Drosophila immune response to monomeric DAP-type peptidoglycan. Nat. Immunol. 7, 715–723 (2006).
Clarke, T. B. et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 16, 228–231 (2010).
Kamareddine, L., Robins, W. P., Berkey, C. D., Mekalanos, J. J. & Watnick, P. I. The Drosophila immune deficiency pathway modulates enteroendocrine function and host metabolism. Cell Metab. 28, 449–462.e445 (2018).
Wong, A. C., Vanhove, A. S. & Watnick, P. I. The interplay between intestinal bacteria and host metabolism in health and disease: Lessons from Drosophila melanogaster. Dis. Model. Mech. 9, 271–281 (2016).
Rooks, M. G. & Garrett, W. S. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16, 341–352 (2016).
Ugur, B., Chen, K. & Bellen, H. J. Drosophila tools and assays for the study of human diseases. Dis. Model. Mech. 9, 235–244 (2016).
Capo, F., Wilson, A. & Di Cara, F. The Intestine of Drosophila melanogaster: An emerging versatile model system to study intestinal epithelial homeostasis and host-microbial interactions in humans. Microorganisms 7, 336 (2019).
Lee, K. A. & Lee, W. J. Drosophila as a model for intestinal dysbiosis and chronic inflammatory diseases. Dev. Comp. Immunol. 42, 102–110 (2014).
Buchon, N., Broderick, N. A., Poidevin, M., Pradervand, S. & Lemaitre, B. Drosophila intestinal response to bacterial infection: Activation of host defense and stem cell proliferation. Cell Host Microbe 5, 200–211 (2009).
Vodovar, N. et al. Complete genome sequence of the entomopathogenic and metabolically versatile soil bacterium Pseudomonas entomophila. Nat. Biotechnol. 24, 673–679 (2006).
Kleino, A. & Silverman, N. The Drosophila IMD pathway in the activation of the humoral immune response. Dev. Comp. Immunol. 42, 25–35 (2014).
Kwon, Y. et al. Systemic organ wasting induced by localized expression of the secreted insulin/IGF antagonist ImpL2. Dev. Cell. 33, 36–46 (2015).
Gateff, E. & Schneiderman, H. A. Developmental capacities of benign and malignant neoplasms of Drosophila. Wilhelm Roux Arch. Entwickl Mech. Org. 176, 23–65 (1974).
Chaput, C. & Boneca, I. G. Peptidoglycan detection by mammals and flies. Microbes Infect. 9, 637–647 (2007).
Paredes, J. C., Welchman, D. P., Poidevin, M. & Lemaitre, B. Negative regulation by amidase PGRPs shapes the Drosophila antibacterial response and protects the fly from innocuous infection. Immunity 35, 770–779 (2011).
Zaidman-Remy, A. et al. The Drosophila amidase PGRP-LB modulates the immune response to bacterial infection. Immunity 24, 463–473 (2006).
Lee, K. A. et al. Bacterial-derived uracil as a modulator of mucosal immunity and gut-microbe homeostasis in Drosophila. Cell 153, 797–811 (2013).
Gottar, M. et al. The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein. Nature 416, 640–644 (2002).
Davies, S. A. et al. Epithelial function in the Drosophila Malpighian tubule: An in vivo renal model. Methods Mol. Biol. 1926, 203–221 (2019).
Denholm, B. et al. The tiptop/teashirt genes regulate cell differentiation and renal physiology in Drosophila. Development 140, 1100–1110 (2013).
Tzou, P. et al. Tissue-specific inducible expression of antimicrobial peptide genes in Drosophila surface epithelia. Immunity 13, 737–748 (2000).
Jung, A. C., Denholm, B., Skaer, H. & Affolter, M. Renal tubule development in Drosophila: A closer look at the cellular level. J. Am. Soc. Nephrol. 16, 322–328 (2005).
Britton, J. S., Lockwood, W. K., Li, L., Cohen, S. M. & Edgar, B. A. Drosophila’s insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional conditions. Dev. Cell. 2, 239–249 (2002).
Hwangbo, D. S., Gershman, B., Tu, M. P., Palmer, M. & Tatar, M. Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body. Nature 429, 562–566 (2004).
Lee, S. & Dong, H. H. FoxO integration of insulin signaling with glucose and lipid metabolism. J. Endocrinol. 233, R67–R79 (2017).
Teleman, A. A. Molecular mechanisms of metabolic regulation by insulin in Drosophila. Biochem. J. 425, 13–26 (2009).
Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471–484 (2006).
Gao, X. & Pan, D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15, 1383–1392 (2001).
Festi, D. et al. Gut microbiota and metabolic syndrome. World J. Gastroenterol. 20, 16079–16094 (2014).
Figueroa-Clarevega, A. & Bilder, D. Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting. Dev. Cell. 33, 47–55 (2015).
Davoodi, S. et al. The immune deficiency pathway regulates metabolic homeostasis in Drosophila. J. Immunol. 202, 2747–2759 (2019).
Dionne, M. S., Pham, L. N., Shirasu-Hiza, M. & Schneider, D. S. Akt and FOXO dysregulation contribute to infection-induced wasting in Drosophila. Curr. Biol. 16, 1977–1985 (2006).
Suzawa, M., Muhammad, N. M., Joseph, B. S. & Bland, M. L. The toll signaling pathway targets the insulin-like peptide Dilp6 to inhibit growth in Drosophila. Cell Rep. 28, 1439–1446.e1435 (2019).
Troha, K. et al. Nephrocytes remove microbiota-derived peptidoglycan from systemic circulation to maintain immune homeostasis. Immunity 51, 625-637.e623 (2019).
Soderberg, J. A., Birse, R. T. & Nassel, D. R. Insulin production and signaling in renal tubules of Drosophila is under control of tachykinin-related peptide and regulates stress resistance. PLoS ONE 6, e19866 (2011).
Rangan, G., Wang, Y. & Harris, D. NF-kappaB signalling in chronic kidney disease. Front. Biosci. 14, 3496–3522 (2009).
Thomas, S. S., Zhang, L. & Mitch, W. E. Molecular mechanisms of insulin resistance in chronic kidney disease. Kidney Int. 88, 1233–1239 (2015).
Huang, Z. et al. Antibody neutralization of microbiota-derived circulating peptidoglycan dampens inflammation and ameliorates autoimmunity. Nat. Microbiol. 4, 766–773 (2019).
Cheung, W. W., Paik, K. H. & Mak, R. H. Inflammation and cachexia in chronic kidney disease. Pediatr. Nephrol. 25, 711–724 (2010).
Millet-Boureima, C., Porras Marroquin, J. & Gamberi, C. Modeling renal disease “On the Fly”. Biomed. Res. Int. 2018, 5697436 (2018).
Leulier, F., Rodriguez, A., Khush, R. S., Abrams, J. M. & Lemaitre, B. The Drosophila caspase Dredd is required to resist gram-negative bacterial infection. EMBO Rep. 1, 353–358 (2000).
Georgel, P. et al. Drosophila immune deficiency (IMD) is a death domain protein that activates antibacterial defense and can promote apoptosis. Dev. Cell. 1, 503–514 (2001).
Volkenhoff, A. et al. Glial glycolysis is essential for neuronal survival in Drosophila. Cell Metab. 22, 437–447 (2015).
Kurz, C. L., Charroux, B., Chaduli, D., Viallat-Lieutaud, A. & Royet, J. Peptidoglycan sensing by octopaminergic neurons modulates Drosophila oviposition. Elife 6, e21937 (2017).
Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E. & Hariharan, I. K. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105, 345–355 (2001).
Khush, R. S., Cornwell, W. D., Uram, J. N. & Lemaitre, B. A ubiquitin-proteasome pathway represses the Drosophila immune deficiency signaling cascade. Curr. Biol. 12, 1728–1737 (2002).
Sarkissian, M., Mendez, R. & Richter, J. D. Progesterone and insulin stimulation of CPEB-dependent polyadenylation is regulated by Aurora A and glycogen synthase kinase-3. Genes Dev. 18, 48–61 (2004).
Acknowledgements
Funding was provided by Agence Nationale de la Recherche (Grant no. ANR-18-CE15-0018-02) and Fondation pour la Recherche Médicale (Grant no. EQU201903007783).
Author information
Authors and Affiliations
Contributions
J.R., R.T. and O.Z. conceived the experiments. R.T. and O.Z. performed them and analyzed the data. O.Z. and J.R. wrote the manuscript. J.R. secured funding and supervised the research.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zugasti, O., Tavignot, R. & Royet, J. Gut bacteria-derived peptidoglycan induces a metabolic syndrome-like phenotype via NF-κB-dependent insulin/PI3K signaling reduction in Drosophila renal system. Sci Rep 10, 14097 (2020). https://doi.org/10.1038/s41598-020-70455-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-020-70455-7
This article is cited by
-
Microbiota in a long survival discourse with the human host
Archives of Microbiology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.